Search results
Results from the WOW.Com Content Network
It now expects revenue in the range of $59.5 billion to $62.5 billion, up from $58.5 billion to $61.5 billion — with a combined $8.5 billion expected from the COVID vaccine and COVID treatment ...
The respiratory vaccines are priced lower than other vaccines, like Merck's HPV vaccine, Gardasil, which has a list price of $300 or more. (List price for Moderna's COVID vaccine: $110.) (List ...
On 14 October, Botswana received a first batch of 49,200 doses under the supply agreement with Moderna reached in June 2021. One week later, it received 72,000 doses of the Janssen vaccine purchased through the African Vaccine Acquisition Trust, followed by 72,000 more doses of the same vaccine on 25 October and 57,600 doses on 30 October.
The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID), and the Biomedical Advanced Research and Development Authority (BARDA). Depending on the jurisdiction, it is authorized for use in ...
The facility set a goal of supplying COVID‑19 vaccines to nearly 100 low-to-middle income countries that could not afford them. COVAX sought to fundraise US$6.8 billion to purchase and deliver vaccines to participating countries in proportion to their populations. [ 32 ]
The COVID-19 vaccination campaign in the United States is an ongoing mass immunization campaign for the COVID-19 pandemic in the United States. The Food and Drug Administration (FDA) first granted emergency use authorization to the Pfizer–BioNTech vaccine on December 10, 2020, [ 7 ] and mass vaccinations began four days later. The Moderna ...
The company expects that the U.S. demand for the vaccine would reach 50 to 100 million doses in the fall season. Moderna continues to expect 2023 COVID sales of $6 to $8 billion.
t. e. Valneva COVID-19 vaccine is a COVID-19 vaccine developed by French biotechnology company Valneva SE in collaboration with the American biopharmaceutical company Dynavax Technologies. [7][8][9] In April 2022, the United Kingdom Medicines and Healthcare products Regulatory Agency (MHRA) approved the vaccine, being the first in the world to ...